J-Star Holding Co., Ltd (NASDAQ:YMAT) Shares Shorted: Short Interest Up 237.5% in September

J-Star Holding Co., Ltd (NASDAQ:YMAT) was the target of a large increase in short interest in the month of September. As of September 15th, there was short interest totaling 65,449 shares, an increase of 237.5% from the August 31st total of 19,393 shares. Approximately 2.0% of the company’s shares are short sold. Based on an average daily volume of 3,670,029 shares, the days-to-cover ratio is presently 0.0 days.

Analyst Upgrades and Downgrades

YMAT has been the topic of a number of recent research reports. Wall Street Zen upgraded shares of J-Star to a “hold” rating in a report on Saturday, June 27th. Weiss Ratings downgraded J-Star from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, July 9th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has an average rating of “Sell”.

J-Star Stock Performance

Shares of NASDAQ:YMAT traded up $0.13 during trading on Friday, hitting $1.56. 914,253 shares of the company’s stock were exchanged, compared to its average volume of 3,803,338. J-Star has a 52-week low of $0.85 and a 52-week high of $13.00. The business’s 50-day simple moving average is $1.83 and its 200 day simple moving average is $2.38.

J-Star Company Profile

J-Star Holding Co, Ltd. is a pharmaceutical research and development services company that supports pharmaceutical and biotechnology businesses throughout the drug-development process. Through its operating subsidiaries, the company provides contract development services designed to help clients advance drug candidates from early development through clinical manufacturing.

J-Star’s services include preformulation studies, formulation development, analytical method development and validation, stability testing, and the production of clinical trial materials.